No Data
New Research Illustrates How to Drive Earlier Diagnosis and Treatment of Kidney Disease
A new survey in partnership with the National Kidney Foundation finds that discussions between patients and providers, and patient activation, are key to helping high-risk patients take preventive actions to manage
D.A. Davidson Maintains Phreesia(PHR.US) With Buy Rating
D.A. Davidson analyst Gil Luria maintains $Phreesia(PHR.US)$ with a buy rating.According to TipRanks data, the analyst has a success rate of 45.8% and a total average return of 7.6% over the past year
J.P. Morgan Maintains Phreesia(PHR.US) With Buy Rating, Cuts Target Price to $27
J.P. Morgan analyst Anne Samuel maintains $Phreesia(PHR.US)$ with a buy rating, and adjusts the target price from $28 to $27.According to TipRanks data, the analyst has a success rate of 45.5% and a t
Phreesia, Inc. (PHR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
NEW YORK--(BUSINESS WIRE)--$PHR #classaction--Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Phreesia, Inc. ("Phreesia" or "the C
Express News | Phreesia Outlook FY Revenue USD 416-426 Million
Phreesia, Inc. (NYSE:PHR) Just Released Its First-Quarter Results And Analysts Are Updating Their Estimates
There's been a notable change in appetite for Phreesia, Inc. (NYSE:PHR) shares in the week since its first-quarter report, with the stock down 18% to US$18.62. Revenues of US$101m arrived in li